Compare Archer-Daniels-Midland Co (ADM) vs Adaptive Biotechnologies Corp (ADPT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Archer-Daniels-Midland Co vs Adaptive Biotechnologies Corp — how do they compare? Archer-Daniels-Midland Co trades at $80.23 (market cap $38.78B), while Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B). The key difference: Archer-Daniels-Midland Co is far larger — about 9.6× Adaptive Biotechnologies Corp's market cap, and Archer-Daniels-Midland Co pays a 2.59% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADM | ADPT | |
|---|---|---|
Market Cap | $38.78B | $4.04B |
Sector | Consumer Staples | Health |
52-Week High | $87.32 | $25.45 |
52-Week Low | $56.00 | $12.30 |
Enterprise Value | $47.03B | $4.10B |
Dividend Yield | 2.59% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Archer-Daniels-Midland Co
Archer-Daniels Midland is a major processor of oilseeds, corn, wheat, and other agricultural commodities. Additionally, the company owns an extensive network of logistical assets to store and transport crops around the globe. ADM also runs a nutrition business that focuses on both human and animal ingredients. The company is also a large producer of corn-based sweeteners, starches, and ethanol.
Read more on ADM →About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →
